U.S. Auto Components Stock News

Sagebrush Health Services has filed a lawsuit against Amgen (NasdaqGS:AMGN), accusing the company of improperly ending discounted drug sales under the federal 340B Drug Pricing Program. The complaint also alleges Amgen sought to claw back millions of dollars in prior discounts, affecting access to lower cost medications for underserved patients. The case raises questions about Amgen's 340B practices, its relationships with nonprofit clinics, and potential regulatory and reputational...

ICF International (ICFI) has attracted fresh attention after securing two multi year contracts with European institutions to lead public communication campaigns across all 27 EU Member States, with a combined ceiling near US$300 million. See our latest analysis for ICF International. The recent EU contract wins come as ICF International’s share price trades at US$95.96, with a 30 day share price return of 12.16% and a year to date gain of 12.48%. However, the 1 year total shareholder return...

What recent returns say about Victoria's Secret (VSCO) Victoria's Secret (VSCO) has drawn fresh attention after a mixed short term performance, with a 4.2% decline over the past day, a 2.8% gain over the week, and a 14% rise over the past month. See our latest analysis for Victoria's Secret. That recent 14% 1 month share price return sits within a stronger upswing, with an 87.8% 90 day share price return and a 62.5% 1 year total shareholder return suggesting momentum has been building rather...

Gold Royalty (GROY) drew fresh attention after reporting preliminary revenue of US$4,501,000 for the quarter and US$15,610,000 for 2025, compared with US$3,355,000 and US$10,103,000, respectively, a year earlier. See our latest analysis for Gold Royalty. Those preliminary revenue figures land at a time when Gold Royalty’s share price has shown strong momentum, with a 30 day share price return of 17.38% and a 1 year total shareholder return of over 3x, suggesting sentiment has shifted...

Analysts are paying closer attention to Federal Realty Investment Trust (FRT) after a series of asset sales and acquisitions that reshape its retail focused portfolio and have drawn supportive views from firms such as Jefferies and Scotiabank. See our latest analysis for Federal Realty Investment Trust. At a share price of US$101.66, Federal Realty’s recent 1-day and 7-day share price returns of a 0.78% and 0.14% decline contrast with modestly positive 30-day and year to date gains. Its...

BGC Group stock after recent performance shifts BGC Group (BGC) has recently drawn attention after mixed share performance, including a modest move over the past month and a small decline across the past 3 months, prompting investors to reassess the brokerage and financial technology firm. See our latest analysis for BGC Group. At a share price of $9.17, BGC Group’s recent 7-day share price return of 2.46% and year-to-date share price return of 2.57% contrast with a 1-year total shareholder...

Tilray Brands: recent performance snapshot Tilray Brands (TLRY) has drawn investor attention after a 5.3% gain over the past day, which contrasts with weaker returns over the week, month, and past 3 months and has prompted closer scrutiny of its recent share performance. See our latest analysis for Tilray Brands. That 5.3% 1 day share price gain comes after weaker momentum, including a 13.3% 30 day share price return and a 38.7% 90 day share price return. At the same time, the 1 year total...

BD (NYSE:BDX) is expanding its partnership with Ypsomed to develop a 5.5 mL Neopak XtraFlow prefillable syringe aimed at large volume, high viscosity biologic drugs. The new syringe is designed to support more efficient self-administration and streamlined pharmaceutical development for biologic treatments. Separately, BD received FDA clearance for its EnCor EnCompass Breast Biopsy and Tissue Removal System, a multi modality device for breast health procedures. BD, trading at $206.04, is...

Earlier this week, technology hardware stocks including Pure Storage benefited after the U.S. administration called off planned tariffs on European allies, easing trade tensions and inflation worries that had weighed on growth-focused names. The shift away from tariff uncertainty has renewed investor interest in Pure Storage’s all-flash data platform, which supports long-term customer commitments and flexible capital allocation options. We’ll now explore how easing U.S.–Europe tariff...

Wondering whether Texas Pacific Land is priced fairly at around US$345.78, or if the current share price is out of step with its fundamentals? This article will focus squarely on what you are getting for the price you pay. The stock has returned 4.5% over the last 7 days and 16.3% over the last 30 days. Year to date it is up 16.0%, but it shows a 25.7% decline over the last year and a 53.9% return over 3 years, with a very large 5 year return of about 3x. Recent coverage of Texas Pacific...

Sysco (NYSE:SYY) is contending with weak sales volume growth, reflecting softer demand for its foodservice distribution offerings. At the same time, the company reports better returns on invested capital, supported by recent investments in its operations. Sysco is also expected to see improvements in free cash flow margin, pointing to tighter cost control and more disciplined capital use. For investors watching Sysco at a share price of $76.84, the story right now is a mix of demand...

Why TriCo Bancshares Is On Investors’ Radar Today TriCo Bancshares (TCBK) is drawing attention after reporting fourth quarter and full year 2025 earnings that topped analyst forecasts, along with a new share repurchase authorization covering up to 2,000,000 common shares. See our latest analysis for TriCo Bancshares. The latest 1 day share price return of 4.24% brings TriCo Bancshares to US$50.61, building on a 90 day share price return of 17.56% and a 1 year total shareholder return of...

In recent days, Intellia Therapeutics has drawn fresh attention as ARK Invest extended a three-day buying streak in the stock, even as its ATTR program remains on clinical hold and analysts offered mixed ratings ranging from Sell to Hold and Buy. This combination of renewed institutional interest alongside unresolved safety concerns and limited commercial visibility for key programs highlights a complex risk‑reward profile for investors to assess. With this backdrop of ARK’s continued buying...

H&R Block (NYSE:HRB) introduced a no cost Tax Pro Review for new customers using its paid online DIY tax products. The service targets taxpayers facing major tax code changes, pairing digital filing with access to a tax professional. The offering is positioned as part of H&R Block's broader hybrid, omni channel model across online, virtual, and office services. For you as an investor, this move sits at the intersection of tax preparation and online financial services, where complexity in...

Why Allegion Stock Is On Investors’ Radar Today Allegion (ALLE) has drawn fresh attention after recent share moves, with the stock up 1.8% over the past week and about 3.2% over the past month, despite a roughly 3.1% decline in the past 3 months. See our latest analysis for Allegion. Looking beyond the latest move, Allegion’s share price has a 1-year total shareholder return of 27.24% and a 3-year total shareholder return of 53.00%, while shorter term share price momentum has cooled slightly...

Why Zeta Global Holdings (ZETA) is on investors’ radar Zeta Global Holdings (ZETA) has drawn attention recently as investors weigh its share price of US$20.45 against its current fundamentals. These include annual revenue of US$1.22b and a reported net loss of US$22.81 million. See our latest analysis for Zeta Global Holdings. Recent trading has been choppy, with a 2.20% 1 day share price return and an 8.25% 7 day share price decline. However, a 30 day share price return of 11.63% and a 90...

Paramount Television Studios has signed the first lease at Sunset Pier 94 Studios, Vornado Realty Trust's new film and television complex in Manhattan. The agreement marks a key step toward opening Manhattan's first purpose built production facility and advancing the site's role in local community development. For investors watching Vornado Realty Trust (NYSE:VNO), the Paramount lease puts fresh attention on a company better known for its office and retail footprint. Shares closed at...

Fitch Ratings assigns Nextpower (NasdaqGS:NXT) its first investment grade credit rating. Nextpower completes a joint venture with Abunayyan Holding in Saudi Arabia, including a new regional headquarters and advanced manufacturing facility. The new facility is intended to support solar infrastructure build out across the Middle East and North Africa. Nextpower, trading at $100.32, is drawing fresh attention as it pairs a new investment grade rating from Fitch Ratings with a recently...

U.S. GoldMining (USGO) has drawn fresh attention after releasing initial 2025 exploration results from its Whistler Project in Alaska, outlining several new high priority gold copper targets across the Whistler Orbit area. See our latest analysis for U.S. GoldMining. The initial 2025 Whistler results have arrived alongside a sharp pick up in market interest, with U.S. GoldMining’s latest share price at $14.20 and a 30 day share price return of 47.61% feeding into a 61.73% year to date share...

Dollar General recently expanded its myDG Delivery same-day service to more than 17,000 stores, offering one free delivery per myDG account between January 20 and February 28, 2026, and deepening ties with DoorDash and Uber Eats through its app and website. This push brings app-based same-day delivery to many rural communities that previously had limited access to home delivery, marking a significant step in Dollar General’s broader omnichannel and digital engagement efforts. We’ll now...

The recent U.S. FDA draft guidance endorsing minimal residual disease and complete response as endpoints in multiple myeloma, together with new 2026 Tandem Meetings data, has drawn fresh attention to Arcellx (ACLX) and its lead CAR T program. See our latest analysis for Arcellx. After the FDA draft guidance and the new 2026 Tandem Meetings data, Arcellx’s recent 5.66% 1 month share price return stands against an 18.08% 3 month share price decline and a very large 3 year total shareholder...

Novavax (NasdaqGS:NVAX) has signed a licensing agreement with Pfizer covering the use of its Matrix-M adjuvant technology in up to two infectious disease areas. The deal includes upfront payments to Novavax, with the potential for future milestone payments and royalties tied to Pfizer’s use of Matrix-M. The agreement signals industry interest in Novavax’s adjuvant platform and introduces new potential revenue channels alongside its own vaccine programs. For you as an investor, this puts...

Updated guidance shifts attention to Vericel Vericel (VCEL) has put out preliminary unaudited guidance for the fourth quarter and full year 2025, flagging 23% revenue growth for the quarter and an expected US$276 million in net revenue for the year. The company also anticipates GAAP net income profitability for a second straight year, a detail many investors watch closely when considering how a commercial stage biotech is converting its product portfolio into earnings. See our latest analysis...

Zoetis (NYSE:ZTS) has launched new next generation osteoarthritis treatments, Lenivia and Portela. The products are designed to address safety concerns linked to earlier osteoarthritis pain drugs Librela and Solensia. Both treatments are long acting and require less frequent administration, targeting continuity of care and market share in osteoarthritis pain management. Zoetis, a major animal health company, is expanding its osteoarthritis portfolio with Lenivia and Portela, which aim to...